ZY

ZHENGYE BIOTECHNOLOGY HLDG L

ZYBT·G989MS101·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic

ZYBT (ZHENGYE BIOTECHNOLOGY HLDG L) is held by 6 institutional investors as of Q2 2026. Largest holders: XTX Topco Ltd ($33,086), GEODE CAPITAL MANAGEMENT, LLC ($19,681), UBS Group AG ($5,410). Net institutional sentiment: Mixed.

6
Holders
$59,438
Total Value
50% (4)
Consensus
2 buying - 2 selling
13F: Insider & Congress: Updated regularly
ZY

Smart Money Verdict

View all
Loading verdict
Held by 6 funds

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for ZYBT.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
48,865(+10.7%)$33,0860.0%+11.25%
22
Unchanged
29,068$19,6810.0%-72.31%
0
Decreased
7,992(-0.6%)$5,4100.0%-50.89%
0
Unchanged
1,230$1,0000.0%+107.46%
0
Decreased
248(-5.0%)$1680.0%-72.20%
0
New
134$930.0%+170.31%
17
ZYZYBTZHENGYE BIOTECHNOLOGY HLDG L

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used